Financial Year |
March 31 2023 |
Monetary Funds |
2,743,913,570.30 |
Held-for-trading Financial Assets |
1,648,613,330.66 |
Notes Receivable |
-- |
Accounts Receivable |
206,154,418.90 |
Advances to Suppliers |
49,219,117.27 |
Other Receivables |
4,022,733.14 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
688,682,017.41 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
201,332,602.74 |
Other Current Assets |
52,988,520.49 |
Total Current Assets |
5,624,401,155.95 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
1,832,315,489.03 |
Under-construction Projects |
1,825,876,533.40 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
286,375,929.65 |
R&D expenses |
763,195,658.48 |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
10,188,537.25 |
Deferred Income Tax Assets |
129,840,423.54 |
Other Non-Current Assets |
82,839,345.01 |
Sub-Total of Non-Current Assets |
4,971,476,050.45 |
Total Assets |
10,595,877,206.40 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
86,498,900.23 |
Accounts Received In Advance |
251,992.33 |
Employee Compensation Payable |
154,687,740.62 |
Taxes Payable |
12,649,650.38 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
425,058,907.73 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
8,960,940.95 |
Other Current Liabilities |
361,262.21 |
Sub-Total of Current Liabilities |
743,706,276.32 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
11,427,974.65 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
206,873,265.58 |
Total Liabilities |
950,579,541.90 |
Paid-In Capital(Or Share Stock) |
565,653,200.00 |
Capital Surplus |
2,574,560,120.12 |
Surplus Reserve |
291,531,843.96 |
LESS:Treasury Stock |
71,364,020.00 |
Undistributed Profits |
6,282,759,871.69 |
Minority Stockholder's Interest |
-162,559.01 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,645,460,223.51 |
Owner's Equity(Stockholder's Equity) |
9,645,297,664.50 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
10,595,877,206.40 |